Advyzon Investment Management, LLC

Position in HRMY — Harmony Biosciences Holdings, Inc.

CIK 2011872 LISLE, IL

Position in HRMY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$734,316

+$198,513 QoQ

Shares Held

20,168

+5.4% QoQ

Ownership

0.035%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

#161

of 325 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Advyzon Investment Management, LLC holds $2,492,343 across 4 Biotechnology names. HRMY ranks #2 (29.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,740	$864,309
2	HRMY	Harmony Biosciences Holdings, Inc. This page	20,168	$734,316
3	EXEL	Exelixis, Inc.	9,563	$520,322
4	ARWR	Arrowhead Pharmaceuticals, Inc.	4,581	$373,396

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$734,316	20,168	+5.4%	Shares	Other	2026-08-14
2026-03-31	$535,803	19,129	+8.1%	Shares	Other	2026-05-12
2025-12-31	$662,259	17,698	—	Shares	Other	2026-02-13
No filing history on record for this holder in this stock.